Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and Lipodystrophy

cetylpyridinium chloride anhydrous has been researched along with Lipodystrophy in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baker, DJ; Childs, BG; Durik, M; Jeganathan, KB; Khazaie, K; Miller, JD; Pezeshki, A; Saltness, RA; Sieben, CJ; van Deursen, JM; Verzosa, GC; Wijers, ME; Zhong, J1

Other Studies

1 other study(ies) available for cetylpyridinium chloride anhydrous and Lipodystrophy

ArticleYear
Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan.
    Nature, 2016, Feb-11, Volume: 530, Issue:7589

    Topics: Adipocytes; Aging; Animals; Apoptosis; Cell Separation; Cell Transformation, Neoplastic; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p16; Epithelial Cells; Female; Health; Kidney; Lipodystrophy; Longevity; Male; Mice; Myocardium; Organ Specificity; Stem Cells; Time Factors

2016